Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas
- PMID: 3102156
- DOI: 10.1016/0732-8893(87)90101-5
Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas
Abstract
Eleven strains of tobramycin-susceptible Pseudomonas aeruginosa, 12 strains of tobramycin-resistant P. aeruginosa, and 11 strains of P. maltophilia were tested against tobramycin in combination with azlocillin, piperacillin, ceftazidime, and imipenem and against colistin in combination with azlocillin, piperacillin, ceftazidime, and imipenem by microdilution checkerboard and time-kill curve techniques. Synergistic or additive effects were demonstrated in the tobramycin-ceftazidime combination against tobramycin-resistant strains of P. aeruginosa and P. maltophilia, and with all tobramycin combinations against tobramycin-susceptible strains of P. aeruginosa using the checkerboard technique. Synergistic and additive effects were seen with the time-kill curve technique with colistin-ceftazidime, colistin-imipenem, and tobramycin-piperacillin combinations against tobramycin-susceptible P. aeruginosa and in the colistin-ceftazidime combination against tobramycin-resistant P. aeruginosa. Fractional inhibitory concentrations (FIC) and fractional bactericidal concentrations (FBC) from checkerboard studies were compared to the time-kill curve results and vice versa. The overall agreement with FIC was 39.4% and 40.9% and agreement with FBC was 40.9% and 43.9%. This limited study illustrates the lack of agreement between these techniques in demonstrating antimicrobial synergy against pseudomonads.
Similar articles
-
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.Yonsei Med J. 2010 Jan;51(1):111-6. doi: 10.3349/ymj.2010.51.1.111. Epub 2009 Dec 29. Yonsei Med J. 2010. PMID: 20046523 Free PMC article.
-
Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa.Infect Dis (Lond). 2020 Sep;52(9):616-624. doi: 10.1080/23744235.2020.1767803. Epub 2020 May 19. Infect Dis (Lond). 2020. PMID: 32427010
-
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2006 Jun;50(6):2228-30. doi: 10.1128/AAC.01620-05. Antimicrob Agents Chemother. 2006. PMID: 16723591 Free PMC article.
-
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.Diagn Microbiol Infect Dis. 1986 May;5(1):17-23. doi: 10.1016/0732-8893(86)90087-8. Diagn Microbiol Infect Dis. 1986. PMID: 3086026
-
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0. Am J Med. 1986. PMID: 3088998 Review.
Cited by
-
Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.Antimicrob Agents Chemother. 2001 Dec;45(12):3328-33. doi: 10.1128/AAC.45.12.3328-3333.2001. Antimicrob Agents Chemother. 2001. PMID: 11709304 Free PMC article.
-
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.Yonsei Med J. 2010 Jan;51(1):111-6. doi: 10.3349/ymj.2010.51.1.111. Epub 2009 Dec 29. Yonsei Med J. 2010. PMID: 20046523 Free PMC article.
-
In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.J Vet Med Sci. 2017 Sep 12;79(9):1472-1479. doi: 10.1292/jvms.17-0180. Epub 2017 Jul 29. J Vet Med Sci. 2017. PMID: 28757508 Free PMC article.
-
In vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosis.PLoS One. 2015 Feb 17;10(2):e0116545. doi: 10.1371/journal.pone.0116545. eCollection 2015. PLoS One. 2015. PMID: 25689777 Free PMC article.
-
Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.Antimicrob Agents Chemother. 1988 May;32(5):782-4. doi: 10.1128/AAC.32.5.782. Antimicrob Agents Chemother. 1988. PMID: 3395107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources